Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James MacCabe

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
BMJ Open|November 26, 2021
Cross-sectional study comparing cognitive function in treatment responsive versus treatment non-responsive schizophrenia: evidence from the STRATA studyEdward Millgate, Eugenia Kravariti, Alice Egerton, et al.
Schizophrenia Research|July 30, 2017
Utilising symptom dimensions with diagnostic categories improves prediction of time to first remission in first-episode psychosisOlesya Ajnakina, John Lally, Marta Di Forti, et al.
The British Journal of Psychiatry : the Journal of Mental Science|April 19, 2022
Real-world clinical and cost-effectiveness of community clozapine initiation: mirror cohort studyEmma Butler, Toby Pillinger, Kirsten Brown, et al.
BMJ Open|November 21, 2022
Cognitive function and treatment response trajectories in first-episode schizophrenia: evidence from a prospective cohort studyEdward Millgate, Kira Griffiths, Alice Egerton, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|April 7, 2023
An automatic analysis framework for FDOPA PET neuroimagingGiovanna Nordio, Rubaida Easmin, Alessio Giacomel, et al.
The Lancet. Psychiatry|June 17, 2023
An international research agenda for clozapine-resistant schizophreniaJurjen J Luykx, Jairo M Gonzalez-Diaz, Ta-Wei Guu, et al.
JAMA Psychiatry|June 24, 2026
Neurometabolites and Antipsychotic Response in Psychosis: A Mega-AnalysisBridget King, Kirsten Borup Bojesen, Charlotte Crisp, et al.
Elife|March 1, 2021
DNA methylation meta-analysis reveals cellular alterations in psychosis and markers of treatment-resistant schizophreniaEilis Hannon, Emma L Dempster, Georgina Mansell, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
BMJ Open|November 26, 2021
Cross-sectional study comparing cognitive function in treatment responsive versus treatment non-responsive schizophrenia: evidence from the STRATA studyEdward Millgate, Eugenia Kravariti, Alice Egerton, et al.
Schizophrenia Research|July 30, 2017
Utilising symptom dimensions with diagnostic categories improves prediction of time to first remission in first-episode psychosisOlesya Ajnakina, John Lally, Marta Di Forti, et al.
The British Journal of Psychiatry : the Journal of Mental Science|April 19, 2022
Real-world clinical and cost-effectiveness of community clozapine initiation: mirror cohort studyEmma Butler, Toby Pillinger, Kirsten Brown, et al.
BMJ Open|November 21, 2022
Cognitive function and treatment response trajectories in first-episode schizophrenia: evidence from a prospective cohort studyEdward Millgate, Kira Griffiths, Alice Egerton, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|April 7, 2023
An automatic analysis framework for FDOPA PET neuroimagingGiovanna Nordio, Rubaida Easmin, Alessio Giacomel, et al.
The Lancet. Psychiatry|June 17, 2023
An international research agenda for clozapine-resistant schizophreniaJurjen J Luykx, Jairo M Gonzalez-Diaz, Ta-Wei Guu, et al.
JAMA Psychiatry|June 24, 2026
Neurometabolites and Antipsychotic Response in Psychosis: A Mega-AnalysisBridget King, Kirsten Borup Bojesen, Charlotte Crisp, et al.
Elife|March 1, 2021
DNA methylation meta-analysis reveals cellular alterations in psychosis and markers of treatment-resistant schizophreniaEilis Hannon, Emma L Dempster, Georgina Mansell, et al.
Pageof 4